Utang agregat perusahaan: Trinity Biotech PLC (TRIB)

The stability of Trinity Biotech plc (TRIB) is confirmed by sales of CGM monitors and HIV tests, as evidenced by the changes in debt load displayed on GURU.Markets; 0.00 serves as the current parameter value. The business relies on global supplies of reagents for diabetes diagnostics. Resilience is ensured by the installed instrument base and asset optimization, which protects the company's current margins.

Trinity Biotech Corp - Utang perusahaan TRIB (periode 04.07.2022 - 27.10.2026)

Rincian metrik lan analitis perusahaan Trinity Biotech plc (TRIB)

- rega lan prakiraan konsensus rega:

Rega bursa trinitybiotech.com|TRIB - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar Trinity Biotech Corp|TRIB - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Buku saben Saham Trinity Biotech|TRIB - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku trinitybiotech.com|TRIB - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Trinity Biotech plc|TRIB - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas trinitybiotech.com|TRIB - Gunggung utang perusahaan|Utang-utang marang nilai buku Trinity Biotech Corp

Pambiji fundamental perusahaan:Trinity Biotech PLC TRIB

This metric is critical when stress-testing business resilience to credit risks and assessing the issuer's solvency. The total volume of borrowed funds, reflected through total liabilities, measures the aggregate debt load, where the downward debt trend for Trinity Biotech plc (TRIB) signifies the release of resources for expansion into the wearable biosensors segment while maintaining a narrow specialization in laboratory diagnostics.

Pesaing wigati